Acrp Ccrc/Cra Acrp/ Acrp-Cp Certification Exam
Bundle|Questions And Answers 100% Correct!
Domain 1: Ethical and Participant Safety Considerations
Question 1
The Belmont Report (1979) established three core ethical principles for the
protection of human subjects. Which principle requires that research subjects be
treated as autonomous agents capable of making informed decisions about their
participation?
A. Beneficence
B. Respect for Persons
C. Justice
D. Non-maleficence
Rationale: The Belmont Report's principle of Respect for Persons requires that
individuals be treated as autonomous agents and that those with diminished
autonomy are entitled to protection. Beneficence addresses maximizing benefits
and minimizing harms, while Justice concerns fair distribution of research burdens
and benefits. Non-maleficence, while related, is not one of the three named
Belmont principles.
Question 2
A clinical trial sponsor proposes recruiting economically disadvantaged individuals
from a single community for a Phase III study investigating an expensive oncology
drug. Under the Belmont principle of Justice, which concern is MOST relevant?
A. The study lacks scientific merit
B. The community may be systematically selected for availability rather than
reasons related to the problem being studied
,C. The informed consent form is too complex for the population
D. The study drug should be provided free of charge during the trial
Rationale: The Belmont principle of Justice requires that subject selection be
scrutinized to ensure classes are not systematically selected for their availability,
compromised position, or manipulability rather than for reasons directly related
to the problem being studied. Recruiting solely from an economically
disadvantaged community raises concerns about exploiting vulnerability and
unfair distribution of research burdens and benefits.
Question 3
The Nuremberg Code (1947) was developed as a direct consequence of which
historical event?
A. The Tuskegee Syphilis Study
B. Nazi medical experiments during World War II
C. The thalidomide tragedy
D. The Beecher article publication
Rationale: The Nuremberg Code was established in 1947 as a result of the
Nuremberg Trials, which prosecuted Nazi physicians for conducting horrific and
unethical medical experiments on concentration camp prisoners during World
War II. It established foundational requirements for voluntary consent, scientific
merit, and the right of subjects to terminate participation at any time.
Question 4
A subject in a Phase I oncology trial experiences nausea with vomiting after IP
infusion which results in an inpatient hospitalization lasting 23 hours. The site
coordinator should classify this event as:
A. An adverse event (AE) only
B. A serious adverse event (SAE)
,C. An unexpected adverse drug reaction
D. A protocol deviation
Rationale: According to ICH E2A, a serious adverse event is any untoward
medical occurrence that results in death, is life-threatening, requires inpatient
hospitalization or prolongation of existing hospitalization, results in persistent or
significant disability/incapacity, or is a congenital anomaly/birth defect. Inpatient
hospitalization triggers SAE classification regardless of duration.
Question 5
According to the ICH-E2A, what is the initial reporting timeline required by the
sponsor for all other serious, unexpected ADRs?
A. ≤ 7 calendar days
B. ≤ 15 calendar days
C. ≤ 24 hours
D. ≤ 30 calendar days
Rationale: Per ICH E2A, "As soon as possible, but no later than 15 calendar
days after first knowledge by the sponsor" for serious, unexpected suspected
adverse reactions that are not fatal or life-threatening. Fatal or life-threatening
unexpected ADRs require reporting as soon as possible but no later than 7
calendar days.
Question 6
A subject is participating in a clinical trial where only the pharmacist and the
sponsor know the identity of the IP. The pharmacist has no direct contact with the
trial subject and the clinical team. Which of the following BEST describes this trial
type?
A. Open-label
B. Single-blind
, C. Double-blind
D. Triple-blind
Rationale: In a double-blind trial, the subject(s), investigator(s), monitor, and
often the data analyst(s) are unaware of treatment assignments. The pharmacist
maintains the blind and has no contact with subjects or the clinical team, ensuring
neither subjects nor investigators know the treatment.
Question 7
The ICF for a new drug trial contains the statement "There is a possibility that
drugs like this could cause cell changes that could become cancerous." This
statement BEST describes which of the following elements of the ICF?
A. An unforeseeable risk
B. A favorable risk/benefit ratio
C. An unfavorable risk/benefit ratio
D. A foreseeable risk
Rationale: A foreseeable risk is a potential harm that is known or anticipated
based on prior data or the mechanism of action of the investigational product.
The statement describes a known potential risk of the drug class.
Question 8
Which of the following is considered to be an SAE?
A. Skin cancer
B. Transient hypotension
C. Treatment at an urgent care center
D. A congenital anomaly in a male subject's offspring
Rationale: According to ICH E2A, a congenital anomaly or birth defect is one
of the defining criteria for a serious adverse event. Skin cancer may be an AE but
Bundle|Questions And Answers 100% Correct!
Domain 1: Ethical and Participant Safety Considerations
Question 1
The Belmont Report (1979) established three core ethical principles for the
protection of human subjects. Which principle requires that research subjects be
treated as autonomous agents capable of making informed decisions about their
participation?
A. Beneficence
B. Respect for Persons
C. Justice
D. Non-maleficence
Rationale: The Belmont Report's principle of Respect for Persons requires that
individuals be treated as autonomous agents and that those with diminished
autonomy are entitled to protection. Beneficence addresses maximizing benefits
and minimizing harms, while Justice concerns fair distribution of research burdens
and benefits. Non-maleficence, while related, is not one of the three named
Belmont principles.
Question 2
A clinical trial sponsor proposes recruiting economically disadvantaged individuals
from a single community for a Phase III study investigating an expensive oncology
drug. Under the Belmont principle of Justice, which concern is MOST relevant?
A. The study lacks scientific merit
B. The community may be systematically selected for availability rather than
reasons related to the problem being studied
,C. The informed consent form is too complex for the population
D. The study drug should be provided free of charge during the trial
Rationale: The Belmont principle of Justice requires that subject selection be
scrutinized to ensure classes are not systematically selected for their availability,
compromised position, or manipulability rather than for reasons directly related
to the problem being studied. Recruiting solely from an economically
disadvantaged community raises concerns about exploiting vulnerability and
unfair distribution of research burdens and benefits.
Question 3
The Nuremberg Code (1947) was developed as a direct consequence of which
historical event?
A. The Tuskegee Syphilis Study
B. Nazi medical experiments during World War II
C. The thalidomide tragedy
D. The Beecher article publication
Rationale: The Nuremberg Code was established in 1947 as a result of the
Nuremberg Trials, which prosecuted Nazi physicians for conducting horrific and
unethical medical experiments on concentration camp prisoners during World
War II. It established foundational requirements for voluntary consent, scientific
merit, and the right of subjects to terminate participation at any time.
Question 4
A subject in a Phase I oncology trial experiences nausea with vomiting after IP
infusion which results in an inpatient hospitalization lasting 23 hours. The site
coordinator should classify this event as:
A. An adverse event (AE) only
B. A serious adverse event (SAE)
,C. An unexpected adverse drug reaction
D. A protocol deviation
Rationale: According to ICH E2A, a serious adverse event is any untoward
medical occurrence that results in death, is life-threatening, requires inpatient
hospitalization or prolongation of existing hospitalization, results in persistent or
significant disability/incapacity, or is a congenital anomaly/birth defect. Inpatient
hospitalization triggers SAE classification regardless of duration.
Question 5
According to the ICH-E2A, what is the initial reporting timeline required by the
sponsor for all other serious, unexpected ADRs?
A. ≤ 7 calendar days
B. ≤ 15 calendar days
C. ≤ 24 hours
D. ≤ 30 calendar days
Rationale: Per ICH E2A, "As soon as possible, but no later than 15 calendar
days after first knowledge by the sponsor" for serious, unexpected suspected
adverse reactions that are not fatal or life-threatening. Fatal or life-threatening
unexpected ADRs require reporting as soon as possible but no later than 7
calendar days.
Question 6
A subject is participating in a clinical trial where only the pharmacist and the
sponsor know the identity of the IP. The pharmacist has no direct contact with the
trial subject and the clinical team. Which of the following BEST describes this trial
type?
A. Open-label
B. Single-blind
, C. Double-blind
D. Triple-blind
Rationale: In a double-blind trial, the subject(s), investigator(s), monitor, and
often the data analyst(s) are unaware of treatment assignments. The pharmacist
maintains the blind and has no contact with subjects or the clinical team, ensuring
neither subjects nor investigators know the treatment.
Question 7
The ICF for a new drug trial contains the statement "There is a possibility that
drugs like this could cause cell changes that could become cancerous." This
statement BEST describes which of the following elements of the ICF?
A. An unforeseeable risk
B. A favorable risk/benefit ratio
C. An unfavorable risk/benefit ratio
D. A foreseeable risk
Rationale: A foreseeable risk is a potential harm that is known or anticipated
based on prior data or the mechanism of action of the investigational product.
The statement describes a known potential risk of the drug class.
Question 8
Which of the following is considered to be an SAE?
A. Skin cancer
B. Transient hypotension
C. Treatment at an urgent care center
D. A congenital anomaly in a male subject's offspring
Rationale: According to ICH E2A, a congenital anomaly or birth defect is one
of the defining criteria for a serious adverse event. Skin cancer may be an AE but
